GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dabomb Protein Biotech 6578.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

16.90

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 309.3m

FY2016FY2025

Net income

−TWD 69.3m

FY2016FY2025

Free cash flow

−TWD 21.0m

FY2016FY2025

Shareholders' equity

TWD 989.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 309.3mTWD 337.8mTWD 384.4mTWD 433.6mTWD 470.6mTWD 605.2mTWD 646.6mTWD 622.9mTWD 562.4mTWD 726.8m
Gross profitTWD 69.0mTWD 68.7mTWD 46.4mTWD 19.3mTWD 21.7mTWD 99.3mTWD 129.7mTWD 117.3mTWD 121.2mTWD 167.2m
Research and developmentTWD 16.2mTWD 14.9mTWD 13.6mTWD 11.9mTWD 11.8mTWD 14.1mTWD 11.3mTWD 6.0mTWD 5.2mTWD 5.1m
Operating income−TWD 65.1mTWD 16.2m−TWD 54.0m−TWD 44.9m−TWD 69.5mTWD 14.2mTWD 39.1mTWD 31.2mTWD 41.1mTWD 83.5m
Net income−TWD 69.3mTWD 11.6m−TWD 57.0m−TWD 44.7m−TWD 62.4mTWD 7.2mTWD 21.2mTWD 25.1mTWD 28.0mTWD 68.3m
Diluted earnings per share-1.060.18-0.91-1.13-1.590.240.720.380.431.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.10bnTWD 1.32bnTWD 1.40bnTWD 1.28bnTWD 1.34bnTWD 1.06bnTWD 919.4mTWD 841.9mTWD 851.1mTWD 819.9m
Cash and short-term investments——TWD 429.5mTWD 232.0mTWD 266.9mTWD 313.5m————
Total liabilitiesTWD 106.5mTWD 226.0mTWD 443.8mTWD 552.9mTWD 662.2mTWD 356.7mTWD 221.0mTWD 131.4mTWD 228.3mTWD 200.1m
DebtTWD 19.4mTWD 45.4mTWD 418.0mTWD 496.0mTWD 618.3mTWD 292.5mTWD 156.7mTWD 73.8mTWD 175.4mTWD 109.4m
Shareholders' equityTWD 989.3mTWD 1.09bnTWD 958.1mTWD 727.2mTWD 674.2mTWD 700.5mTWD 698.4mTWD 710.5mTWD 622.8mTWD 619.8m
Shares outstanding65m65m63m40m39m30m29m65m65m65m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 16.6mTWD 47.6mTWD 6.5mTWD 19.7m−TWD 44.3mTWD 13.4mTWD 33.3mTWD 22.1mTWD 43.9mTWD 59.6m
Capital spending−TWD 37.7m−TWD 30.3m−TWD 18.9m−TWD 20.2m−TWD 332.1m−TWD 18.3m−TWD 91.8m−TWD 163.1m−TWD 166.5m−TWD 92.7m
Free cash flow−TWD 21.0mTWD 17.2m−TWD 12.4m−TWD 449,000−TWD 376.3m−TWD 4.9m−TWD 58.6m−TWD 141.0m−TWD 122.6m−TWD 33.1m
Dividends paid−TWD 12.2m———−TWD 6.0m−TWD 14.7m−TWD 23.4m−TWD 12.8m−TWD 21.9m−TWD 27.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 107.5mTWD 82.1mTWD 80.9mTWD 69.0mTWD 90.9mTWD 68.6mTWD 81.7mTWD 57.0m
Gross profitTWD 28.0mTWD 18.0mTWD 19.0mTWD 15.8mTWD 19.2mTWD 15.0mTWD 17.3mTWD 10.6m
Operating incomeTWD 10.1mTWD 747,000—−TWD 21.1mTWD 4.4mTWD 4.0m−TWD 438,000−TWD 4.2m
Net incomeTWD 9.2mTWD 5.6m−TWD 44.3m−TWD 12.4m−TWD 14.8mTWD 2.1mTWD 1.1m−TWD 1.5m
Diluted earnings per share0.140.09-0.68-0.17-0.230.030.02-0.02
Cash from operationsTWD 12.0mTWD 5.0m——−TWD 13.0mTWD 8.0mTWD 3.0mTWD 19.0m
Capital spending——−TWD 9.0m—−TWD 3.0m−TWD 20.0m−TWD 6.0m−TWD 20.0m
Free cash flow————−TWD 16.0m−TWD 12.0m−TWD 3.0m−TWD 1.0m
Total assetsTWD 1.12bnTWD 1.09bnTWD 1.10bnTWD 1.19bnTWD 1.23bnTWD 1.29bnTWD 1.32bnTWD 1.32bn
Cash and short-term investments———TWD 220.0m————
DebtTWD 9.7mTWD 14.6mTWD 19.4mTWD 91.4mTWD 30.0mTWD 37.7mTWD 45.4mTWD 53.1m
Shareholders' equityTWD 1.01bnTWD 998.5mTWD 989.3mTWD 1.03bnTWD 1.03bnTWD 1.10bnTWD 1.09bnTWD 1.03bn

Financial ratios

Data as of 3 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin22.3%20.3%12.1%4.5%4.6%16.4%—
Operating margin-20.5%6.3%-12.4%-9.8%-14.2%2.3%—
Net margin-22.4%3.4%-14.8%-10.3%-13.3%1.2%—
Return on equity-7.0%1.1%-6.0%-6.1%-9.3%1.0%—
Return on assets-6.3%0.9%-4.1%-3.5%-4.7%0.7%—
Free cash flow yield—6.9%2.3%5.8%42.2%6.1%24.6%
Revenue growth-8.4%-12.1%-11.3%-7.9%-22.2%-6.4%—
Earnings growth-695.8%-120.4%27.7%-28.5%-968.1%-66.1%—
Current ratio2.67x3.66x2.18x1.57x1.80x1.70x—
Debt to equity0.02x0.04x0.44x0.68x0.91x0.41x—
Equity ratio90.3%82.8%68.3%56.8%50.4%66.3%—
Interest coverage-20.61x4.09x-5.80x-6.46x-14.65x5.49x—
R&D as a share of sales5.2%4.4%3.5%2.7%2.5%2.3%—
Buybacks as a share of market value—-4.3%-58.6%-0.5%-30.5%-2.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.6%-12.6%-9.1%
Operating income13.2%——
Net income15.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin21.3%13.9%12.8%17.4%
Operating margin-7.5%-10.1%-8.0%1.3%
Net margin-8.9%-10.9%-8.4%-0.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-18.0111.2-23.0-14.2-11.080.930.454.060.026.5
Price to sales4.03.83.41.51.51.01.02.23.02.5

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 8 Jul 2025.

FY2025FY2024FY2023
Paid in the year0.400.5090.665
  • 1100-for-1000 split · 23 Aug 2021
  • 1050-for-1000 split · 21 Aug 2017
  • 1050-for-1000 split · 25 Aug 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.